The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples